Goldman Sachs analysts reiterated a Buy rating on Edwards Lifesciences Corporation (NYSE:EW) on February 11, 2026. Edwards Lifesciences Corporation operates in the Healthcare…
Goldman Sachs analysts reiterated a Buy rating on Edwards Lifesciences Corporation (NYSE:EW) on February 11, 2026.
Edwards Lifesciences Corporation operates in the Healthcare sector. The stock currently trades at $75.87 with a market capitalization of $49.5B.
Current market data
NYSE · EW
$91.60
Down: -$0.96 · -1.04%
Live quote updated
Keep reading
earnings ·
institutional ·
analyst ·
analyst ·
